Chimerix, Inc. (CMRX) Financials

CMRX Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2024 146.0 million 24.3 million
Sept. 30, 2024 158.7 million 22.9 million
June 30, 2024 178.5 million 22.9 million
March 31, 2024 194.0 million 19.9 million

CMRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2024 -19.4 million 2.2 million
Sept. 30, 2024 -20.5 million 2.4 million
June 30, 2024 -17.8 million 2.2 million
March 31, 2024 -17.7 million 2.7 million

CMRX Net Income

No data available :(

CMRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2024 131.6 million 458000 458000
Sept. 30, 2024 136.2 million 644000 644000
June 30, 2024 148.2 million 827000 827000
March 31, 2024 159.0 million 1.0 million 1.0 million

CMRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2024 90.3 million
Sept. 30, 2024 89.7 million
June 30, 2024 89.6 million
March 31, 2024 89.3 million

CMRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2024 163000 17.7 million 7.0 million -
Sept. 30, 2024 26000 19.6 million 5.2 million -
June 30, 2024 71000 18.4 million 4.5 million -24000
March 31, 2024 27000 18.8 million 5.5 million 3000

CMRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2024 57000 -
Sept. 30, 2024 26000 -
June 30, 2024 129000 24000
March 31, 2024 - -3000

CMRX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CMRX

Price: $8.54

52 week price:
0.75
8.55

Earnings Per Share: -0.99 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 701000

Ebitda: -17.6 million

Market Capitalization: 801.1 million

Links: